Skip to content
Screener

Myriad Genetics MYGN Shares (Diluted)

Shares (Diluted) at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
112M-0.9%
NeoGenomics logo
NeoGenomicsNEO
130.8M+2.3%
Veracyte logo
VeracyteVCYT
81.3M+1.6%
Sera Prognostics logo
Sera PrognosticsSERA
50.3M+19.8%
Guardant Health logo
Guardant HealthGH
131.3M+6.0%
Natera, Inc. logo
Natera, Inc.NTRA
143.3M+5.1%

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36—

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$310.86M-46.0%
Enterprise value$396.36M-38.7%
P/S0.4×-0.3×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%—

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 6:05 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000899923-26-000038
(in millions)Three months ended March 31, 20262025
Denominator:
Weighted-average shares outstanding used to compute basic EPS93.791.4
Effect of dilutive shares——
Weighted-average shares outstanding and dilutive securities used to compute diluted EPS93.791.4

Item 1. Financial Statements.

FAQ

What is Myriad Genetics's shares (diluted)?
Myriad Genetics (MYGN) reported shares (diluted) of 93.7M in Q1 2026.
How has Myriad Genetics's shares (diluted) changed year-over-year?
Myriad Genetics's shares (diluted) increased by 2.5% year-over-year, from 91.4M to 93.7M.
What is the long-term trend for Myriad Genetics's shares (diluted)?
Over 4 years (2021 to 2025), Myriad Genetics's shares (diluted) has grown at a 4.3% compound annual growth rate (CAGR), from 312.7M to 369.6M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Myriad Genetics's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude